Clinical Trial Update: Study of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid Tumors [Phase 2]

View source ↗

Summary

This notice reports a Phase 2 clinical trial evaluating a PD-L1 inhibitor in combination with strategies targeting DNA damage and angiogenesis in advanced solid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Leiomyosarcoma
• Pancreatic Cancer

Snippet

Sponsor: University Health Network, Toronto | Conditions: Mismatch Repair Proficient Colorectal Cancer, Pancreatic Adenocarcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING